European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

TransTissue Technologies GmbH, Berlin, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

TransTissue Technologies GmbH

Identification

Ut
District Court of Charlottenburg (Berlin) HRB 76253 B
EUID
DEF1103R.HRB76253B

Address

Charitéplatz 1, 10117 Berlin, Germany

Corporate purpose

Distribution, including the import and export of pharmaceuticals and other chemical and biological products, medical devices, cosmetics, foodstuffs and related items, and the provision of related services and development services, with the exception of activities subject to authorisation.

Financials

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Network

Loading network

DATA SERVICES

Unlock the full potential of processed company data with our API or Quarterly Exports.

Publications

22 Jun 2021
Wordmark: “TransTissue“
23 Dec 2020 in Hor
EU funding (€340,529): INK-BASED HYBRID MULTI-MATERIAL FABRICATION OF NEXT GENERATION IMPLANTS
30 Nov 2020
Original document: “Liste der Gesellschafter“
1 Jan 2019 in Fk
Public funding (€55,386): Clinical Evidence: Absorbable Implant for Mobility-Preserving Spinal Surgery (RepairDisc) _Ausbildungsbeihilfe
1 Jan 2019 in Fk
Public funding: Clinical Evidence: Absorbable Implant for Mobility-Preserving Spinal Surgery (RepairDisc) _Innovationsbeihilfe
1 Oct 2017 in Fk
Public funding (€260,022): SME-Innovativ-19: OsteoBioCement - Biotechnologically modified calcium phosphate cement for stabilization of osteoporotic vertebral body fractures - Pharmacokinetics and …
1 Oct 2017 in Fk
Public funding (€260,022): SME-Innovativ-19: OsteoBioCement - Biotechnologically modified calcium phosphate cement for stabilization of osteoporotic vertebral body fractures - Pharmacokinetics and …
4 Mar 2016
Managing Director: Michaela Endres · No longer Managing Director: Eszter Tánczos
1 May 2015 in Fk
Public funding (€250,755): Development of a factor-induced, cell-free targeting implant for the closure and regeneration of the anulus fibrosus in intervertebral disc defects (CLOSEDISC) …
14 Jul 2014
Address
1 Jan 2014 in Fk
Public funding (€269,594): Regenerative Medicine - Products for the treatment of skin and cartilage defects, subproject: Research of a bioactive PRP biomaterial implant (PRP = platelet-rich plasma) …
1 Apr 2013 in Fk
Public funding (€345,175): Cell-free bioactive implants made of bacterial nanocellulose collagen bruschite for the regeneration of cartilage bone defects (ZINKII) - Sub-projects: In-situ recruitment …
11 Oct 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011
1 Jan 2012 in Fts
EU funding (€273,915): The Production of a 3D Human Tissue Disease Platform to Enable Regenerative Medicine Therapy Development
9 Nov 2011
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010
7 Jul 2011
The entry for the business address is supplemented ex officio in accordance with § 3 EGGmbHG: Business address ...
26 Jun 2011
Wordmark: “TTT“
24 Jan 2011
Annual report for the year ending 31/12/2009
17 Jan 2011
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
7 Dec 2009
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008
1 Oct 2009 in Fk
Public funding (€271,747): QuReGe Composite: Functional Quality Assurance of Regenerative Tissue Replacement Materials, Subproject: Establishment of Quality Markers for In vitro Culture
6 Jul 2009 via BioTissue Technologies GmbH
Shareholder: BioTissue Technologies GmbH
29 Jun 2009
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007
1 Jun 2008 in Fk
Public funding (€483,561): Bioactive implants for the repair and regeneration of soft tissue defects (BioInside) - Sub-projects: In situ Recruitment of mesenchymal cells for soft tissue regeneration
21 Feb 2008
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006
1 Jun 2005 in Fk
Public funding (€55,777): Development of an interacting 3D test system as a disease model of rheumatoid arthritis (in vitro Pannus model) for effective testing of active substances, subproject 2
10 Sept 2004
Managing Director: Eszter Tánczos · No longer Managing Director (1)
21 Jul 2004
Reg­is­tra­tion · MD (1) · Capital: €25,000 · Share­holder agreement · Seat: Berlin · Name: TransTissue Technologies GmbH · Proxy policy …
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "TransTissue Technologies GmbH, Berlin, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.